KIYATEC: Funding, Investors & Team (Oct 2026)
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co‐culture, and is a single-use disposable. 3DKUBE cell‐based assays leverage these features to create better in vitro prediction of complex biochemical responses in humans, with a focus on the evaluation of drug toxicity and efficacy prior to use in human clinical trials.
KIYATEC has raised $18.0M across 2 funding rounds on record, the most recent an undisclosed round announced in May 2023.
KIYATEC Company Profile and Key Stats
Latest funding round on record: May 2023.
KIYATEC Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
KIYATEC raised $18.0M in a Series C announced in Dec 2022.
5 months later, an undisclosed round was announced in May 2023 with no disclosed amount.
KIYATEC Founders and Leadership Team
No contact details are on record for this team yet.
KIYATEC Funding Compared to Other Biotechnology Startups
Funded Startups Like KIYATEC in Biotechnology and Greenville
Companies Similar to KIYATEC
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
KIYATEC Funding FAQs
What does KIYATEC do?
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co‐culture, and is a single-use disposable. 3DKUBE cell‐based assays leverage these features to create better in vitro prediction of complex biochemical responses in humans, with a focus on the evaluation of drug toxicity and efficacy prior to use in human clinical trials.
How much funding has KIYATEC raised?
KIYATEC has raised $18.0M across 2 rounds on record.
When did KIYATEC last raise funding?
KIYATEC's most recent funding round on record was announced in May 2023. The amount was not disclosed.
Who is the CEO of KIYATEC?
Matthew R Gevaert is listed as CEO at KIYATEC.
Where is KIYATEC headquartered?
KIYATEC is based in Greenville, South Carolina, United States.
How many employees does KIYATEC have?
KIYATEC is in the 11-50 employee band.
About FundedIQ's KIYATEC Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KIYATEC is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.